FR2775287B1 - Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o - Google Patents

Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o

Info

Publication number
FR2775287B1
FR2775287B1 FR9802212A FR9802212A FR2775287B1 FR 2775287 B1 FR2775287 B1 FR 2775287B1 FR 9802212 A FR9802212 A FR 9802212A FR 9802212 A FR9802212 A FR 9802212A FR 2775287 B1 FR2775287 B1 FR 2775287B1
Authority
FR
France
Prior art keywords
hiv
detection
group
synthetic peptides
virus infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9802212A
Other languages
English (en)
Other versions
FR2775287A1 (fr
Inventor
Denis Marie Bernard Chenebaux
Jean Francois Hubert Delagneau
Stephane Jean Xavier Gadelle
Francois Yves Rieunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Rad Innovations SAS
Original Assignee
Pasteur Sanofi Diagnostics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9802212A priority Critical patent/FR2775287B1/fr
Application filed by Pasteur Sanofi Diagnostics SA filed Critical Pasteur Sanofi Diagnostics SA
Priority to DE69836265T priority patent/DE69836265T2/de
Priority to PT98920571T priority patent/PT973802E/pt
Priority to US09/147,362 priority patent/US7053175B1/en
Priority to RU99123443/04A priority patent/RU2184742C2/ru
Priority to IL13216698A priority patent/IL132166A0/xx
Priority to AT98920571T priority patent/ATE343590T1/de
Priority to CA2286344A priority patent/CA2286344C/fr
Priority to PCT/FR1998/000691 priority patent/WO1998045323A1/fr
Priority to KR10-1999-7009296A priority patent/KR100451312B1/ko
Priority to PL336115A priority patent/PL194863B1/pl
Priority to CNB988052024A priority patent/CN1215082C/zh
Priority to AU73386/98A priority patent/AU740231B2/en
Priority to TR1999/02757T priority patent/TR199902757T2/xx
Priority to NZ500015A priority patent/NZ500015A/en
Priority to BRPI9809078A priority patent/BRPI9809078B8/pt
Priority to CZ0357599A priority patent/CZ300927B6/cs
Priority to EP98920571A priority patent/EP0973802B1/fr
Priority to JP54245598A priority patent/JP3560987B2/ja
Priority to ES98920571T priority patent/ES2275305T3/es
Publication of FR2775287A1 publication Critical patent/FR2775287A1/fr
Priority to IL132166A priority patent/IL132166A/en
Priority to NO19994929A priority patent/NO329149B1/no
Publication of FR2775287B1 publication Critical patent/FR2775287B1/fr
Application granted granted Critical
Priority to US11/402,876 priority patent/US7838001B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
FR9802212A 1997-04-09 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o Expired - Lifetime FR2775287B1 (fr)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR9802212A FR2775287B1 (fr) 1998-02-24 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
BRPI9809078A BRPI9809078B8 (pt) 1997-04-09 1998-04-06 peptídeo sintético utilizáveis nos testes biológicos para a detecção das infecções devido aos vírus hiv1 do grupo o, composição que os compreende, processo de imunodosagem in vitro e kit de diagnóstico.
TR1999/02757T TR199902757T2 (xx) 1997-04-09 1998-04-06 Grup O HIV-1 vir�slerine ba�l� enfeksiyonlar�n tespiti i�in biyolojik testlerde kullan�labilen sentetik peptitler.
RU99123443/04A RU2184742C2 (ru) 1997-04-09 1998-04-06 Синтетические пептиды, применяемые в биологических тестах для обнаружения инфекций, вызванных вирусами вич-1 группы 0
IL13216698A IL132166A0 (en) 1997-04-09 1998-04-06 Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses
AT98920571T ATE343590T1 (de) 1997-04-09 1998-04-06 Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o
CA2286344A CA2286344C (fr) 1997-04-09 1998-04-06 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
PCT/FR1998/000691 WO1998045323A1 (fr) 1997-04-09 1998-04-06 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih-1 du groupe o
KR10-1999-7009296A KR100451312B1 (ko) 1997-04-09 1998-04-06 그룹 오 에이취아이브이-1 바이러스에 기인하는 감염의 검출을 위한 생물학적 시험에 사용가능한 합성 펩티드
PL336115A PL194863B1 (pl) 1997-04-09 1998-04-06 Syntetyczne peptydy, zawierające je kompozycje, zastosowania tych peptydów oraz zestaw diagnostyczny
CNB988052024A CN1215082C (zh) 1997-04-09 1998-04-06 可用于检测o组hiv－1病毒感染的生物试验的合成肽
AU73386/98A AU740231B2 (en) 1997-04-09 1998-04-06 Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
DE69836265T DE69836265T2 (de) 1997-04-09 1998-04-06 Synthetische peptide für testverfahren zur bestimmung der infektion mit virus hiv1 der gruppe o
US09/147,362 US7053175B1 (en) 1997-04-09 1998-04-06 Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
NZ500015A NZ500015A (en) 1997-04-09 1998-04-06 Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
CZ0357599A CZ300927B6 (cs) 1997-04-09 1998-04-06 Syntetický peptid monomerního typu, prostredek, který ho obsahuje, zpusob imunologické in vitro kvantifikace a diagnostický kit pro použití v biologických testech pro identifikaci infekcí zpusobených viry HIV
EP98920571A EP0973802B1 (fr) 1997-04-09 1998-04-06 Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih-1 du groupe o
JP54245598A JP3560987B2 (ja) 1997-04-09 1998-04-06 グループｏ ｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド
ES98920571T ES2275305T3 (es) 1997-04-09 1998-04-06 Peptidos sinteticos utilizables en los ensayos biologicos para la deteccion de infecciones debidas a los virus vih-1 del grupo o.
PT98920571T PT973802E (pt) 1997-04-09 1998-04-06 Peptídeos sintéticos utilizáveis em ensaios biológicos para a detecção de infecções causadas por vírus hiv-1 do grupo o
IL132166A IL132166A (en) 1997-04-09 1999-09-30 Synthetic peptides used in biological tests to detect infections caused by viruses belonging to group O HIV-1
NO19994929A NO329149B1 (no) 1997-04-09 1999-10-08 Syntetiske peptider, blandinger, immunoassaymetode og diagnostiseringssett
US11/402,876 US7838001B2 (en) 1997-04-09 2006-04-13 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9802212A FR2775287B1 (fr) 1998-02-24 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o

Publications (2)

Publication Number Publication Date
FR2775287A1 FR2775287A1 (fr) 1999-08-27
FR2775287B1 true FR2775287B1 (fr) 2000-11-24

Family

ID=9523294

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9802212A Expired - Lifetime FR2775287B1 (fr) 1997-04-09 1998-02-24 Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o

Country Status (1)

Country Link
FR (1) FR2775287B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410044D0 (en) * 1994-05-19 1994-07-06 Int Murex Tech Corp Assay
PT787191E (pt) * 1994-10-20 2007-12-06 Pasteur Institut Sequências nucleotídicas de antigénios retroviraisde vih do tipo (ou sub-tipo) o
FR2731013B1 (fr) * 1995-02-27 1997-05-16 Inst Nat Sante Rech Med Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
WO1996027012A1 (fr) * 1995-03-02 1996-09-06 Akzo Nobel N.V. Antigenes specifiques du vih-1, groupe o

Also Published As

Publication number Publication date
FR2775287A1 (fr) 1999-08-27

Similar Documents

Publication Publication Date Title
DE69524365D1 (de) Verfahren zur Isolierung und Reinigung von 2'-Deoxy-2',2'-difluornucleosiden
DE69532492D1 (de) Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
ATE363904T1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
DE60030298D1 (de) Absorbierender artikel zur aufnahme von viskosen körperausscheidungsflüssigkeiten
DE69331507T2 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE69517466D1 (de) Material zur Entfernung von HIV und verwandten Substanzen
DE69318693T2 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ITMI940282A0 (it) Procedimento e dispositivo per la depurazione di sostanze sgrassanti
IT1274787B (it) "procedimento per la ulteriore lavorazione di concentrati di kieseritecontenenti langbeinite e anidrite"
DE69826013D1 (de) Eine neue generation des rekombinanten faktor c der hufeisenkrabbe zur erkennung und entfernung von endotoxin
FR2775287B1 (fr) Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
DE69515755T2 (de) Vorrichtung zur Detektion von Bewegungsvektoren
DE69610471T2 (de) Reinigungsmittel und Verfahren zur Reinigung von schädlichem Gas
FR2761993B1 (fr) Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
DE69326147T2 (de) Dampfsterilisierbares system zur inaktivierung viraler verunreinigungen in körperflüssigkeiten
ATE240123T1 (de) Radiopharmazeutische mittel zur bildgebung von infektionen und entzündungen
FR2757179B1 (fr) Procede de preparation d'amides de l'acide acrylique ou methacrylique
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
DE59409831D1 (de) Oligonukleotide für den Nachweis von Enterobacteriaceae
FR2827796B1 (fr) Materiau pour l'elimination des oxydes d'azote avec structure en feuillets
MA25509A1 (fr) Composition destinee au traitement de l'hepatite c
DE69203707T2 (de) Verfahren zur Reinigung von Fluorethanen und Chlorfluorethanen.
DE9421086U1 (de) System zur Überwachung des Materialflusses bei der Aufbereitung von Sterilgut
FR2700342B1 (fr) Compositions pour le nettoyage d'animaux souillés et procédé de mise en Óoeuvre.

Legal Events

Date Code Title Description
CD Change of name or company name
CD Change of name or company name
CJ Change in legal form
PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20